| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/27/2011 | US8026268 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 09/27/2011 | US8026231 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 09/27/2011 | US8026209 Administering a diagnostic agent with a carrier conjugated to a targeting molecule that binds to a lipopolysaccharide-sensitive polypeptide, which is either up-regulated or down-regulated in ECs by exposure to LPS; delivery into the EC vascular barrier and/or across the EC vascular barrier |
| 09/27/2011 | US8026072 Method of identifying compounds that bind BAFF-R |
| 09/27/2011 | US8025887 Avirulent, immunogenic flavivirus chimeras |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/27/2011 | CA2506476C Method of treatment of myocardial infarction |
| 09/27/2011 | CA2453486C The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 09/27/2011 | CA2440630C Metalloproteinase inhibitors |
| 09/27/2011 | CA2412600C Potent immunostimulatory polysaccharides extracted from microalgae |
| 09/27/2011 | CA2400462C Aspirin-triggered lipid mediators |
| 09/27/2011 | CA2370206C Pharmaceutical compositions for inhibition of cytokine production and secretion |
| 09/27/2011 | CA2336218C Neurotrophic factors |
| 09/27/2011 | CA2258728C Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 09/22/2011 | WO2011116353A2 Method for regulating survival and memory of t helper 1 cells |
| 09/22/2011 | WO2011116299A2 Myeloid derived suppressor cell inhibiting agents |
| 09/22/2011 | WO2011115728A2 Polynucleotides that stimulate neutrophils |
| 09/22/2011 | WO2011115458A2 Dual antagonist for tnf-α and il-21 for preventing and treating autoimmune diseases |
| 09/22/2011 | WO2011115456A2 Tnf-α and tweak dual antagonist for the prophylaxis and treatment of autoimmune diseases |
| 09/22/2011 | WO2011115231A1 Osteopontin specific monoclonal antibody |
| 09/22/2011 | WO2011115225A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 09/22/2011 | WO2011115183A1 Novel monocyclic pyrimidine derivative |
| 09/22/2011 | WO2011115173A1 Monomaleate of benzothiazine compound |
| 09/22/2011 | WO2011114645A1 Anti-allergic composition |
| 09/22/2011 | WO2011113895A2 Characterization and validation of inhibitors and ligands of dipeptidyl aminopeptidase iv (dp iv) |
| 09/22/2011 | WO2011113370A1 Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising these compounds |
| 09/22/2011 | WO2011113309A1 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 09/22/2011 | WO2011113293A1 Dihydropteridinone derivatives, preparation method and pharmaceutical use thereof |
| 09/22/2011 | WO2011113203A1 Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising the compounds |
| 09/22/2011 | WO2011113190A1 Pharmaceutical composition for treating aids and preparation method thereof |
| 09/22/2011 | WO2011113160A1 Bacterial vaccine components from staphylococcus aureus and uses thereof |
| 09/22/2011 | WO2011094465A4 Methods of treating autoimmune diseases with dll4 antagonists |
| 09/22/2011 | WO2011047031A3 Eliciting immune responses using recombinant mva viruses expressing hiv env, gag and pol anitgens |
| 09/22/2011 | US20110230637 Modified human thymic stromal lymphopoietin |
| 09/22/2011 | US20110230568 Heating of polymers and other materials using radiation for drug delivery and other applications |
| 09/22/2011 | US20110230550 Compounds, compositions and methods |
| 09/22/2011 | US20110230536 Phenylpyrazole inhibitors of store operated calcium release |
| 09/22/2011 | US20110230521 Pyrazole Compounds As CCR1 Antagonists |
| 09/22/2011 | US20110230519 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/22/2011 | US20110230518 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis |
| 09/22/2011 | US20110230516 CCR1 Antagonists and Methods of Use Therefor |
| 09/22/2011 | US20110230515 Compounds and methods for treatment and prevention of diseases |
| 09/22/2011 | US20110230496 Novel process for preparing highly pure levocetirizine and salts thereof |
| 09/22/2011 | US20110230494 Heteroaryl compounds and uses thereof |
| 09/22/2011 | US20110230490 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/22/2011 | US20110230487 Arylsulfonamide ccr3 antagonists |
| 09/22/2011 | US20110230484 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators |
| 09/22/2011 | US20110230483 Pyridine and Pyrazine derivative for the Treatment of CF |
| 09/22/2011 | US20110230481 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a method of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 09/22/2011 | US20110230468 Fused heterocyclic compounds and uses thereof |
| 09/22/2011 | US20110230464 Purine derivatives useful as p13 kinase inhibitors |
| 09/22/2011 | US20110230463 2h-chromene compound and derivative thereof |
| 09/22/2011 | US20110230462 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230455 Aqueous-based pharmaceutical composition |
| 09/22/2011 | US20110230440 Inhibitors of fatty acid amide hydrolase |
| 09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230391 Fc gamma receptor for the treatment of b cell mediated multiple sclerosis |
| 09/22/2011 | US20110229585 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 09/22/2011 | US20110229576 Hollow silica nanospheres and methods of making same |
| 09/22/2011 | US20110229574 Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
| 09/22/2011 | US20110229573 Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |
| 09/22/2011 | US20110229563 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| 09/22/2011 | US20110229560 Nlrc5 as a target for immune therapy |
| 09/22/2011 | US20110229556 Lipid-coated polymer particles for immune stimulation |
| 09/22/2011 | US20110229550 Acid-Degradable and Bioerodible Modified Polyhydroxylated Materials |
| 09/22/2011 | US20110229525 Modulation of cytokine signaling |
| 09/22/2011 | US20110229523 Modification of allergens for immunotherapy |
| 09/22/2011 | US20110229522 Methods, compositions and vaccines relating to neisseria meningitidis antibodies |
| 09/22/2011 | US20110229521 Nutritional support of the immune system during anti-cancer treatment |
| 09/22/2011 | US20110229520 Mutant pestivirus with mutations in core gene and ns3 region |
| 09/22/2011 | US20110229517 System and process for producing multi-component biopharmaceuticals |
| 09/22/2011 | US20110229516 Adjuvant phase inversion concentrated nanoemulsion compositions |
| 09/22/2011 | US20110229515 Identification of genes |
| 09/22/2011 | US20110229513 LPS Based Vaccines |
| 09/22/2011 | US20110229512 Compositions and methods for diagnosing and treating urinary tract infections |
| 09/22/2011 | US20110229511 Method of modifying the immune response |
| 09/22/2011 | US20110229510 Glycopeptide constructs and uses thereof |
| 09/22/2011 | US20110229509 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/22/2011 | US20110229507 Stable anthrax vaccine formulations |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229504 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 09/22/2011 | US20110229503 Vaccination against malignant melanoma using bcg and/or vaccinia |
| 09/22/2011 | US20110229502 Ablative immunotherapy |
| 09/22/2011 | US20110229501 Organic compounds |
| 09/22/2011 | US20110229500 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 09/22/2011 | US20110229498 Compositions and methods for modulating an immune response |
| 09/22/2011 | US20110229495 Methods for predicting development of auto-immune diseases and treatment of same |
| 09/22/2011 | US20110229490 Lyophilized Formulations of Engineered Anti-IL-23p19 Antibodies |
| 09/22/2011 | US20110229486 Monoclonal Antibodies Against NKG2A |
| 09/22/2011 | US20110229480 Pta072 protein |
| 09/22/2011 | US20110229479 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma |
| 09/22/2011 | US20110229473 Methods for using taci-immunoglobulin fusion proteins |
| 09/22/2011 | US20110229470 Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229461 PD-1 Antibodies |
| 09/22/2011 | US20110229456 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 09/22/2011 | US20110229448 method for identifying antigen-specific regulatory t cells |
| 09/22/2011 | US20110229447 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| 09/22/2011 | US20110229436 Methods for reducing the likelihood of spontaneous abortion during assisted reproduction in a subject |
| 09/22/2011 | US20110229435 Expression and purification of hip/pap and uses therefor |